Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts [Coronary Interventions]

Conclusions—
Patients receiving second-generation DES for the treatment SVG disease have lower rates of in-hospital major adverse cardiovascular events, 30-day mortality, and 1-year mortality, compared with those receiving BMS.

Source: Circulation: Cardiovascular Interventions - April 12, 2017 Category: Cardiology Authors: Iqbal, J., Kwok, C. S., Kontopantelis, E., de Belder, M. A., Ludman, P. F., Large, A., Butler, R., Gamal, A., Kinnaird, T., Zaman, A., Mamas, M. A., on behalf of British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular O Tags: Percutaneous Coronary Intervention Coronary Interventions Source Type: research